Examiner Daniel A. Icet
Grant ratio: 32.3% (17th percentile in Art Unit 3771 among examiners with at least 20 applications). Average office actions per grant: 1.48. Most common rejection type: §103.
Potentially inactive
Last office action in data: June 2026
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 72 | 53.8% | 1.94 |
| Group | 269 | 49.0% | 2.08 |
| Tech Center | 2,671 | 48.4% | 2.01 |
| USPTO | 16,475 | 52.7% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 28 | 42.4% |
| 2 OAs | 9 | 13.6% |
| 3 OAs | 10 | 15.2% |
| 4 OAs | 9 | 13.6% |
| 5+ OAs | 10 | 15.2% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2023 | 11 | 8 | 72.7% |
| 2024 | 15 | 9 | 60.0% |
| 2025 | 22 | 4 | 18.2% |
| 2026 | 17 | 0 | 0.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 66 | 0.0% | 16.7% | 63.6% | 12.1% |
| Action 2 | 38 | 0.0% | 15.8% | 71.1% | 5.3% |
| Action 3 | 29 | 0.0% | 10.3% | 72.4% | 6.9% |
| Action 4 | 19 | 0.0% | 5.3% | 78.9% | 0.0% |
| Action 5 | 10 | 0.0% | 0.0% | 80.0% | 0.0% |
| Action 6 | 5 | 0.0% | 0.0% | 60.0% | 20.0% |
| Action 7 | 1 | 0.0% | 0.0% | 0.0% | 100.0% |
Section 101 rejections
Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.
By year
0.0%
0.0%
2024: AI examples
0.0%
2025: August memo
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Aug. 27, 2026.